NCT03578367 2025-11-10Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)NovartisPhase 2 Completed104 enrolled 11 charts